CAS NO: | 60-18-4 |
包装 | 价格(元) |
200mg | 电议 |
500mg | 电议 |
1 g | 电议 |
5 g | 电议 |
生物活性 |
L-Tyrosine is a non-essential amino acid which can inhibitcitrate synthaseactivity in the posterior cortex. |
||||||||||||||||
IC50& Target |
|
||||||||||||||||
体外研究 (In Vitro) |
L-Tyrosine inhibits citrate synthase activity in the posterior cortex (2.0 and 4.0 mM), malate dehydrogenase is not altered by L-Tyrosine and succinate dehydrogenase is increased in the posterior cortex (0.1-4.0 mM), hippocampus (1.0-4.0 mM), striatum (4.0 mM) and liver (0.1-4.0 mM). When complex I activity is analyzed, inhibition is observed in hippocampus (4.0 mM). In addition to inhibition in the hippocampus, complex II also is inhibited in the posterior cortex (0.1-4.0 mM) and liver (1.0, 2.0 and 4.0 mM). For complex II–III, activity is not altered by L-Tyrosine, and complex IV activity has decreased in the posterior cortex (1.0-4.0 mM) following treatment with L-Tyrosine[1].
|
||||||||||||||||
体内研究 (In Vivo) |
The acute administration of L-Tyrosine inhibits the activity of citrate synthase in the posterior cortex and liver; however, in the striatum, the activity is increased. The results also demonstrate that acute administration of L-Tyrosine inhibits malate dehydrogenase and complex II, II–III and IV of the mitochondrial respiratory chain activity in the posterior cortex and liver of rats. The succinate dehydrogenase enzyme and complex I activity are inhibited in the posterior cortex and increased in the striatum. Furthermore, energy metabolism in the hippocampus is not amended by an acute administration of L-Tyrosine[1].
|
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
181.19 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C9H11NO3 |
||||||||||||||||
CAS 号 |
60-18-4 |
||||||||||||||||
中文名称 |
L-酪氨酸 |
||||||||||||||||
结构分类 |
|
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
1M HCl : 50 mg/mL(275.95 mM;Need ultrasonic) DMSO : 1 mg/mL(5.52 mM;Need ultrasonic)
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。 |